JP2003334088A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003334088A5 JP2003334088A5 JP2002148341A JP2002148341A JP2003334088A5 JP 2003334088 A5 JP2003334088 A5 JP 2003334088A5 JP 2002148341 A JP2002148341 A JP 2002148341A JP 2002148341 A JP2002148341 A JP 2002148341A JP 2003334088 A5 JP2003334088 A5 JP 2003334088A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- polypeptide
- seq
- sequence represented
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002157 polynucleotide Substances 0.000 claims 7
- 102000040430 polynucleotide Human genes 0.000 claims 7
- 108091033319 polynucleotide Proteins 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002148341A JP2003334088A (ja) | 2002-05-22 | 2002-05-22 | ヒト由来の新規Ｋｌｏｔｈｏ様タンパク質及びその遺伝子 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002148341A JP2003334088A (ja) | 2002-05-22 | 2002-05-22 | ヒト由来の新規Ｋｌｏｔｈｏ様タンパク質及びその遺伝子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003334088A JP2003334088A (ja) | 2003-11-25 |
| JP2003334088A5 true JP2003334088A5 (enExample) | 2005-10-27 |
Family
ID=29706244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002148341A Pending JP2003334088A (ja) | 2002-05-22 | 2002-05-22 | ヒト由来の新規Ｋｌｏｔｈｏ様タンパク質及びその遺伝子 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003334088A (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006158339A (ja) * | 2004-12-09 | 2006-06-22 | Kyoto Univ | βＫｌｏｔｈｏ遺伝子、Ｃｙｐ７ａ１遺伝子、及びそれらの利用 |
| TW201446265A (zh) * | 2007-04-02 | 2014-12-16 | 建南德克公司 | 克羅梭（ｋｌｏｔｈｏ）ｂｅｔａ調節劑之用途 |
| SG193860A1 (en) | 2008-06-04 | 2013-10-30 | Amgen Inc | Fgf21 mutants and uses thereof |
| NZ592009A (en) | 2008-10-10 | 2012-11-30 | Amgen Inc | Fgf21 mutants and uses thereof |
| AU2010246038A1 (en) | 2009-05-05 | 2011-12-01 | Amgen Inc. | FGF21 mutants and uses thereof |
| BRPI1011404B1 (pt) | 2009-05-05 | 2022-05-03 | Amgen Inc | Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira |
| CN102465182A (zh) * | 2010-10-29 | 2012-05-23 | 株式会社爱茉莉太平洋 | 检测皮肤活性物质的检测试剂盒和检测皮肤活性物质的方法 |
| TWI728373B (zh) | 2013-12-23 | 2021-05-21 | 美商建南德克公司 | 抗體及使用方法 |
| RS60593B1 (sr) | 2014-01-24 | 2020-08-31 | Ngm Biopharmaceuticals Inc | Antitela koja vezuju domen 2 beta-kloto i postupci za njihovu upotrebu |
| US10800843B2 (en) | 2015-07-29 | 2020-10-13 | Ngm Biopharmaceuticals, Inc. | Beta klotho-binding proteins |
-
2002
- 2002-05-22 JP JP2002148341A patent/JP2003334088A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024041747A5 (enExample) | ||
| JP2006516189A5 (enExample) | ||
| JP2004000251A5 (enExample) | ||
| ATE471370T1 (de) | Varianten von beta-glukosidasen | |
| ATE130869T1 (de) | Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen. | |
| JPH10262686A5 (enExample) | ||
| JP2002517193A5 (enExample) | ||
| JP2004505640A5 (enExample) | ||
| DE60336353D1 (de) | Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| JP2003334089A5 (enExample) | ||
| CA2422295A1 (en) | A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene | |
| JPWO2023038128A5 (enExample) | ||
| MXPA04000397A (es) | Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos. | |
| CA2448347A1 (en) | Novel human hydroxylases and polynucleotides encoding the same | |
| CA2318490A1 (en) | A novel gene for controlling leaf shapes | |
| DE60036676D1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine | |
| CA2340795A1 (en) | Placental organic anion transporter and gene thereof | |
| JP2000262292A5 (enExample) | ||
| ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
| JPH09248190A5 (enExample) | ||
| GB2441941A (en) | An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide | |
| JP2001069994A5 (enExample) | ||
| EP0897984A3 (en) | D-Sorbitol dehydrogenase gene | |
| JP2006525223A5 (enExample) |